CFDE Data Portal | Search BMPR1AP1

	Label	Description
	BMPR1AP1 Gene (Entity type)	ENSG00000219642 - bone morphogenetic protein receptor type 1A pseudogene 1
	GSE236502 paclitaxel 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE174745 dopamine neuron 1 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE240741 L-13 TIME 4 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE192710 ZIC2 ZNF423 inhibition stem cell 4 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE65634 resveratrol fibroblast 7 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Breast 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Pancreas 20-29 vs 70-79 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Testis 20-29 vs 60-69 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Stomach 20-29 vs 70-79 Up Gene Set (Entity type)	A Gene Set from GTEx

BMPR1AP1

ENSG00000219642 - bone morphogenetic protein receptor type 1A pseudogene 1

GSE236502 paclitaxel 2 v 3 human up

A Gene Set from LINCS

GSE174745 dopamine neuron 1 v 8 human up

A Gene Set from LINCS

GSE240741 L-13 TIME 4 v 6 human dn

A Gene Set from LINCS

GSE192710 ZIC2 ZNF423 inhibition stem cell 4 v 3 human up

A Gene Set from LINCS

GSE65634 resveratrol fibroblast 7 v 3 human up

A Gene Set from LINCS

GTEx Breast 20-29 vs 40-49 Up

A Gene Set from GTEx

GTEx Pancreas 20-29 vs 70-79 Down

A Gene Set from GTEx

GTEx Testis 20-29 vs 60-69 Up

A Gene Set from GTEx

GTEx Stomach 20-29 vs 70-79 Up

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.